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ABSTRACT  DnA demethylation in mammalia occurs after fertilization and during embryogenesis and accompanies cell aging and cancer transformation. With the 
help of the primer extension reaction, MALDI MS and DnA cleavage by thymine DnA glycosylase deamination of 5-methylcytosine residues has been shown to 
take place when the model methylated DnA duplexes are treated with nuclear extracts from the cell lines СНO, HeLa, and Skov3. the hypothesis that deamina-
tion of 5-methylcytosine is the first stage of demethylation in mammalia has been postulated.
Keywords: deamination of 5-methylcytosine, 5-methylcytosine demethylation, the reaction of primer extension, MALDI MS, thymine DnA glycosylase.
Abbreviations: mc – 5-methyl-2’-deoxycytidine, Pcr – polymerase chain reaction, PAAG – polyacrylamide gel, tDG – thymine DnA glycosylase, MALDI MS – 
matrix-assisted laser desorption/ionisation mass spectrometry.
INTRODuCTION
Active DnA demethylation in mammalia is necessary for the 
proper development of the organism, formation of the im-
mune response, and memory. DnA demethylation accompa-
nies the emergence of various diseases and aging.
Global demethylation is observed in the paternal pronuclei 
in the embryos of mice [1], rats, pigs, cows, and humans [2], as 
well as in their germ cells. It provides epigenetic reprogram-
ming and specific gene expression.
Methylation and demethylation of DnA in the cells of 
the nervous system has an influence on synaptic plasticity 
and memory formation. DnA methylation is necessary for 
the inactivation of the gene pp1 that suppresses memory 
processes; whereas active DnA demethylation is associated 
with activation of the gene reelin that promotes the forma-
tion of memory in rats [3]. Also, active DnA demethylation 
is necessary for normal neurogenesis in the embryos of fish 
Danio rerio. Suppression of the expression of protein Gadd45a 
(DnA-damage-inducible protein 45 alpha) or other proteins 
involved in the process of demethylation leads to the death of 
neurons as a result of hypermethylation and suppression of 
the genes responsible for neurogenesis [4].
Methylation and demethylation of DnA is an important 
part of epigenetic control during the immune response [5]. 
Demethylation of the promoter regions of the genes of cy-
tokines il-2 and ifn-γ as a result of cD8 t cells contact with 
antigens leads to rapid expression of cytokines [6-8].
DnA demethylation accompanies cell aging [9]. A differ-
ence in the degree of demethylation in different tissues has 
been shown in rats. the degree of demethylation is higher 
in brain tissues than in liver tissues. Age-related decrease in 
the content of 5-methylcytosine in DnA was also found in 
such cells as lung and skin fibroblasts: for the latter case, the 
connection of demethylation to reduced growth potential in 
culture was shown [10].
Global demethylation of the genome is observed in all ex-
amined cancer cells [11-13]. Hypomethylated sites turned out 
to be numerous repeats, imprinted genes, tissue-specific genes, 
oncogenes, and genes associated with the processes of invasion 
and metastasis of tumors [14, 13]. At the same time, some loci, 
including many tumor-suppressor genes, are hypermethylated, 
which results in suppression of their expression [12, 15, 16].
It is clear that DnA demethylation plays an important role 
in the life of cells, while the mechanism of DnA demethyla-
tion and the participants in this process in mammalia have 
yet to be identified. the aim of this work was to study the 
mechanism of DnA demethylation in mammalian cells.
MATERIALS AND METHODS
Synthesis of oligodeoxyribonucleotides. Oligonucleotides I-
III were synthesized using the amido-phosphite method in 
automatic mode on a synthesizer manufactured by Applied 
Biosystems, with commercial reagents and solvents according 





5’-cAtAcAttAccAtttc (III), where * is the amino group 




mcGmcGAGAAGcttGtAt* (IV), 5’-AtAcAAGcttct 
mcGmcGmcGGttcGAtcGtAGAcAAAAAAAAAA* (V) 
– commercial preparations (“Synthol”).
Cultivation of cell lines and preparation of nuclear extracts. 
continuous cell lines of chinese hamster ovary (cHO), a hu-
man cervical carcinoma (HeLa), and human ovarian adeno-
carcinoma (Skov3) were grown in a standard DMeM medium 
containing 10% fetal serum (FcS), 4 mM L-glutamine, 1 mM 
sodium pyruvate, a streptomycin/penicillin concentration of 
100 μg/ml and 100 u/ml, respectively, at 37° c in an atmo-
sphere of 5% cO2. For subculturing, the cell monolayer was 122 | ActA nAturAe |  № 3 2009
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washed with a PBS buffer (10 mM na2HPO4, 1.5 mM KH2PO4, 
137 mM nacl, 2.7 mM Kcl, pH 7.4), a standard solution of 
trypsin-eDtA (Sigma) was added, and culture bottles were 
placed in a cO2 incubator for 3-5 minutes. then, a medium 
with FcS was added, and cells were suspended by pipetting. 
the cells were then placed in the necessary number of cul-
ture bottles. the cells grown to the monolayer were collected 
by centrifugation at 2300 rpm for 10 minutes at 4° c. they 
were then washed several times with a PBS buffer and ly-
sed in buffer L (20 mM Hepes (pH 7.6), 10 mM nacl, 1.5 mM 
Mgcl2, 20% glycerol, 0.1% triton X100, 1 mM Dtt, cocktail 
of protease inhibitors). After 2 minutes, the lysate was sus-
pended and centrifuged for 20-30s at 10,000 rpm. An equal 
volume of buffer ne (20 mM Hepes (pH 7.6), 500 mM nacl, 
1.5 mM Mgcl2, 20% glycerol, 0.1% triton X100, 1 mM Dtt, a 
cocktail of protease inhibitors) was added to the pellet, then 
it was carefully suspended and placed on a shaker for 30-
60 minutes. then, lysate was centrifuged for 10 minutes at 
10 000 rpm.
Formation of DNA-duplex and treatment with nuclear ex-
tracts from cells. Formation of DnA-duplex I/II proceeded 
on a Pcr thermal cycler by keeping 20 μl of the reaction mix-
ture containing 500 pmol of oligonucleotide I and 550 pmol of 
oligonucleotide II at 95° c for 3 minutes and then cooling the 
thermostat from 95 to 35° c at a speed of 0.5°/min and from 35 
to 20° c at a speed of 0.25°/min.
then, 50 μl of the reaction mixture containing buffer ne, 
10 mM of DnA-duplex I/II, and the nuclear extract corre-
sponding to ~ 50000 cells was incubated at 37° c for 1 hour. 
After a three-fold phenol deproteinization, the DnA duplex 
was precipitated with 2.5 volumes of ethanol, with the addi-
tion of a 1/10 volume of 3 M naOAc (pH 5.5) by keeping for 2 
hours at -20° c. the pellet was precipitated by centrifugation 
at 14000 rpm for 10 minutes, washed with 70% ethanol, dried 
in vacuum, and dissolved in 20 μl of water.
Primer extension reaction. A radioactive label was introduced 
at the 5’-end of primer III in advance. to do this, a 20 μl re-
action mixture containing a buffer solution for t4 polynucle-
otide kinase (500 mM tris-Hcl (pH 7.6), 100 mM Mgcl2, 50 mM 
Dtt, 1 mM spermidine, 1 mM eDtA, 1 mM ADP), 10 mM of 
primer III, 5 units of t4 polynucleotide kinase (MBI Fermen-
tas, 10 units/μl) and 10 mM [γ-32P] AtP (Ge Healthcare, the 
specific activity of 220 tBq/mmol or 6000 ci/mmol) was incu-
bated at 37° c for 1 hour. the enzyme was heat-inactivated for 
15 minutes at 75° c. the 32P-labeled primer III was purified by 
electrophoresis in denaturing 12% PAAG. the area contain-
ing primer III with the radioactive label was visualised using 
autoradiography and excised. Primer III was eluted from the 
gel by adding 400 μl of a GeS buffer (10 mM tris-Hcl (pH 8.0), 
1% SDS, 0.5% triton X100, 50 mM eDtA) supplemented with 
400 μl of phenol with vigorous stirring overnight. the aque-
ous phase was separated by centrifugation at 14000 rpm for 5 
minutes, primer III was precipitated as described above and 
was dissolved in 20 μl of water. the amount of primer III was 
evaluated either by radioactivity or spectrophotometrically by 
the absorption of the solution at 260 nm. After that, 4 μl of the 
solution of DnA-duplex I/II (2.5 mM) and 1 μ of a 10X reac-
tion buffer (500 mM tris-Hcl (pH 8.0), 50 mM Mgcl2, 10 mM 
Dtt) were added to 3 μl of a purified 32P-labeled primer III 
(3.3 mM). Hybridization was performed on the Pcr thermal 
cycler by cooling the thermostat from 70 to 42° c at a speed of 
0.4°/min with keeping a constant temperature for 21 seconds 
and increasing the time of every subsequent cycle by 1 second. 
then, 5 units of Klenow fragment without exonuclease activity 
(MBI Fermentas, 10 units/ul) and 1 μl of a mixture of dAtP, 
dctP, dttP (1 mM each), and ddntP (0.01 mM) were added 
to the reaction mixture. the mixture was incubated at 37° c for 
10 minutes. the reaction was stopped by heating to 75° c for 
10 minutes. Analysis of the products of the primer extension 
reaction was carried out by electrophoresis in denaturing 10% 
PAAG. the gel was dried in vacuum, exposed to the screen of 
a BAS cASSette 2340, and information from the screen was 
read on the FuJIFILM FLA 3000 using the BASreader 3.14 
computer programm.
Treatment of DNA duplexes by thymine DNA glycosylase 
(TDG). A 20 μl reaction mixture containing 0.5 mM of DnA 
duplex I/II, 32P-labeled at one of the DnA strands, 10 units of 
tDG (r & D Systems, 5 u/μl), and the buffer (10 mM Hepes 
(pH 7.4), 100 mM Kcl, 10 mM eDtA) was incubated at 65° 
c for 1 hour. then, a 10 μl of 3-fold alkaline buffer (300 mM 
naOH, 97% formamide, 0.2% bromphenol blue) was added 
to the reaction. It was incubated at 95° c for 10 minutes and 
then rapidly cooled to 2-8° c. the reaction products were ana-
lyzed by electrophoresis in 20% PAAG. the gel was dried us-
ing a vacuum dryer and exposed to the screen of a BAS cAS-
Sette 2340. Information from the screen was read on the 
FuJIFILM FLA 3000 using the BASreader 3.14 program.
Analysis of DNA fragments using mass spectrometry. the bi-
otinylated DnA duplex IV/V was formed as described above 
for the duplex I/II. then, it was treated with nuclear extracts 
from cells, and purification on streptavidin-Sepharose was 
performed. Streptavidin-Sepharose was pre-equilibrated in 
buffer r (100 mM tris-Hcl (pH 7.5), 10 mM Mgcl2, 100 mM 
Kcl, 0.1 mg/ml BSA). For that, 100 μl of a 50% suspension of 
streptavidin-Sepharose was mixed with 200 μl of buffer r 
and incubated with weak stirring for 10-15 minutes. Strepta-
vidin-Sepharose was precipitated by centrifugation at 3000 
rpm for 3-4 minutes, the buffer was replaced, and beads were 
resuspended. the procedure described above was repeated 
Fig. 1. Primer extension reaction with-
out dGTP for methylated oligodeoxyri-
bonucleotide duplex treated with buffer 
for extracts (control) (1), or nuclear 
extract from CHO cell line (2). The 
partial sequence of model oligodeoxyri-
bonucleotide I is shown on the right
primerreSeArcH ArtIcLeS
 № 3 2009  | ActA nAturAe | 123
5 times. A 500 pmol of biotinylated DnA duplex IV/V was 
added to the equilibrated Sepharose. the binding of the du-
plex with Sepharose was carried out under mild stirring at 
4° c for 2-12 hours. then, the resin was washed 6 times by 
1 ml of buffer r, as described above. After that, 30 units of 
restriction endonucleases HindΙΙΙ (MBI Fermentas, 10 u/μl) 
and PvuΙ (MBI Fermentas, 10 u/μl) were added to the reac-
tion mixture and it was kept with low stirring at 37° c for 16 
hours. Streptavidin-Sepharose was sedimented by centrifu-
gation at 5000 rpm for 5 minutes. the obtained fragments 
were separated by electrophoresis in denaturing 20% PAAG. 
the gel was stained with SYBr Green in a buffer solution 
tBe (100 mM tris-Hcl, 100 mM H3BO3, 2 mM eDtA). the 
analyzed fragment was eluted from the gel using the method 
described for the primer. then, samples were concentrated 
and desalted on Ziptip c18 (Millipore). the resin was washed 
with a 50 mM aqueous solution of ammonium citrate, and the 
oligonucleotide was eluted with a solution of 25 mM ammoni-
um citrate in 50% acetonitrile. On the matrix for MALDI MS 
1 μl of the sample, 0.5 μl of a 50 mM solution of ammonium 
citrate and 0.5 μl of 3-hydroxypicoline acid (Fluka, 20 mg / ml 
in acetonitrile) were mixed, then the mixture was dried in air. 
Mass spectra were obtained on the MALDI tOF/tOF mass 
spectrometer ultraflex II BruKer (Germany), equipped 
with a uV laser (nd). Mass spectra were obtained in the mode 
of positive ions in linear fashion.
DISCuSSION OF RESuLTS AND CONCLuSIONS
to study the process of DnA demethylation, complementary 
oligodeoxynucleotides I and II, each containing 3 residues of 
5-methylcytosine in the context of dinucleotide 5’-mcpG, 
which is typical for the mammalian genome, were designed 
and synthesized. For the protection against the nucleases 
present in the cell lysates 3’-protruding ends of DnA-duplex 
I/II carried protective groups.
the extension of primer III was used to monitor changes 
in the nucleotide sequence. Primer III is complementary to 
the 3’-terminal region of oligonucleotide I. In the absence 
of dGtP in the medium and in the presence of ddntP, the 
primer had to be extended up to the first 5-methylcytosine 
residue (lane 1, Fig. 1). After the treatment of DnA-duplex I/
II with nuclear extracts from the cHO cell line longer primer-
extension products appear (lane 2, Fig. 1). this phenomenon 
could be explained by the conversion of 5-methylcytosine into 
thymine; i.e., the deamination process takes place when DnA-
duplex I/II is treated with the extract of cHO cells.
to test this hypothesis, DnA-duplex I/II with three 5’-
mcpG sites was sequentially treated with the nuclear extract 
of cell lines (СHO, HeLa or Skov3) and thymine DnA glyco-
sylase, which recognizes t/G-mismatch and cuts the DnA 
strand containing t (Fig. 2, lanes 2, 3, 4, respectively). After 
the separation of reaction products, new bands correspond-
ing to the position of 5-methylcytosine residues could be de-
tected by autoradiography. that indicates the deamination of 
5-methylcytosine residues.
Fig. 2. The action of 
thymine DNA glycosylase 
on methylated duplex I/
II treated with buffer for 
extracts (control) (1), 
or nuclear extracts from 
cell lines CHO (2), HeLa 
(3), and Skov3 (4). The 
positions of generated DNA 
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Fig. 3. MALDI mass-
spectra obtained 
for methylated DNA 
fragment treated 
with buffer for ex-
tracts (control) (a), 
or nuclear extracts 
from cell lines CHO 
(b), HeLa (c),  
Skov3 (d)124 | ActA nAturAe |  № 3 2009
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Deamination of DnA duplexes after the treatment with 
the nuclear extracts of the cells was shown by MALDI MS. 
For that, we used oligodeoxynucleotide duplex IV/V con-
taining the dinucleotides 5’-mcpG, endonuclease HindΙΙΙ 
and PvuΙ recognition sites, flanking the analyzed fragment 
(underlined), as well as biotin at the 5’-end for the affinity 
isolation of the DnA duplex on streptavidin-Sepharose.
the size of the fragment containing three 5’-mcpG sites 
is 14 nucleotides; its calculated molecular mass is 4404.8 Da 
(Fig. 3, a).
the spectra of the analyzed fragment derived from the 
DnA duplex after the treatment with nuclear extracts from 
cell lines (cHO, HeLa, or Skov3) have a signal at 4408 Da (Fig. 
3, b-d), corresponding to deamination of three 5-methylcyto-
sine residues.
cell lines cHO, HeLa, and Skov3 are derived from cancer 
cells in which global demethylation of the genome is known 
to occur. One can suggest that, the deamination of 5-meth-
ylcytosine observed as a result of the treatment with nu-
clear extracts of these cell lines is the first stage of the DnA 
demethylation in mammalia. It is known that in Danio rerio 
embryos DnA demethylation is a multistep process involving 
deamination of 5-methylcytosine with the deaminases AID 
(Activation Induced deaminase)/Apobec (Apolipo-protein B 
rnA-editing catalytic component), removal of thymine by 
glycosylase MBD4, and Ber-repair [4, 17]. In mammalian 
cells, there are suitable candidates from the cytosine deami-
nases family – AID and Apobec1, which are co-expressed 
with pluripotent genes in oocytes, embryonic germ cells, and 
embryonic stem cells [18]. However, it is known that these 
enzymes perform deamination only in single-stranded rnA 
(Apobec1) or DnA (AID). In addition, AID and Apobec deam-
inate cytosine residues much more effectively than 5-meth-
ylcytosine. DnA methyltransferase Dnmt3b can also perform 
the role of 5-methyl cytosine deaminase when the concentra-
tion of S-adenosylmethionine (AdoMet) is low [19], but this 
reaction takes place with very low efficiency, making its par-
ticipation in the global demethylation unlikely. Moreover, the 
concentration of AdoMet in the cell is usually quite high.
A good candidate for the role of thymine glycosylase is 
MBD4 glycosylase, which contains methyl-binding and gly-
cosylase domains and removs of thymine from t/G-mismatch 
[20]. Although MBD4 deficient mice are viable, mutations in 
the cpG-sites occur more frequently in such mice [21]. MBD4 
removes thymine from t/G-mismatch with the formation of 
apurine site that is immediately cut by AP endonuclease. In the 
symmetrically methylated cpG-sites, the deamination of both 
DnA strands should lead to the formation of the tG/Gt region. 
If MBD4 recognizes such a region then, after the action of AP 
endonuclease, a double break should form, which would lead to 
the loss of genetic material. In addition, MBD4 removes uracil 
from u/G-mismatch faster than thymine from t/G [20].
Another mechanism of DnA demethylation is also known. 
It is observed in plant Arabidopsis thaliana and involves the 
direct removal of the 5-methylcytosine base using bifunction-
al glycosylases/liases (rOS1, DML2, DML3, DMe) followed 
by Ber-repair [22-25]. there are two suitable glycosylase 
in mammalia: thymine DnA glycosylase (tDG) and methyl-
binding protein MBD4. However, both tDG and MBD4 have 
weak 5-methylcytosine glycosylase activity compared to the 
ability to excise thymine [26]. In addition, active demethyla-
tion of paternal chromatin was observed in mouse embryos 
with a knocked-out mbd4 gene [21].
It is worth mentioning other theoretically possible mecha-
nisms of 5-methylcytosine demethylation. this is the direct 
removal of methyl groups with the formation of cytosine and 
excision of one or more nucleotides containing 5-methylcy-
tosine (ner-repair). In vertebrates, there are orthologs of 
bacterial demethylase (oxidoreductase) AlkB responsible for 
direct removal of methyl groups from 1-methyladenine and 
3-methylcytosine in prokaryotes [2]. However, there is no data 
indicating that any of the orthologs can carry demethylation of 
5-methylcytosine. Histone demethylases (HDMs) are homolo-
gous to bacterial AlkB [27], but none of them is involved in DnA 
demethylation. earlier, it was shown that methyl-binding pro-
tein MBD2b can directly remove the methyl group of 5-meth-
ylcytosine with the formation of c and methanol as the reaction 
products [28]. However, this result could not be reproduced in 
other laboratories. Moreover, mice lacking MBD2b had a nor-
mal phenotype and normal pattern of DnA methylation. As for 
the mechanism of DnA demethylation by ner-repair, there is 
no evidence of the occurrence of the process in vivo.
thus, further study of DnA demethylation in mammals is 
necessary to understand the mechanism of this essential life   
process.  
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